These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8673754)

  • 21. Safety of the calcium antagonist lacidipine evaluated from a phase III-IV trial database.
    Lindholm LH; Tcherdakoff P; Zanchetti A
    J Hypertens Suppl; 1996 Sep; 14(2):S15-20. PubMed ID: 8934373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group.
    Uretsky BF; Young JB; Shahidi FE; Yellen LG; Harrison MC; Jolly MK
    J Am Coll Cardiol; 1993 Oct; 22(4):955-62. PubMed ID: 8409069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of age on neurohormonal activation and prognosis in patients with chronic heart failure.
    van Veldhuisen DJ; Boomsma F; de Kam PJ; Man in't Veld AJ; Crijns HJ; Hampton JR; Lie KI
    Eur Heart J; 1998 May; 19(5):753-60. PubMed ID: 9717009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension.
    Lee CR; Bryson HM
    Drugs; 1994 Aug; 48(2):274-96. PubMed ID: 7527328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
    J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.
    Drexler H; Banhardt U; Meinertz T; Wollschläger H; Lehmann M; Just H
    Circulation; 1989 Mar; 79(3):491-502. PubMed ID: 2521816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta blockade in congestive heart failure: persistent adverse haemodynamic effects during chronic treatment with subsequent doses.
    Kukin ML; Kalman J; Mannino MM; Buchholz-Varley C; Ocampo O
    Heart; 1997 Nov; 78(5):444-9. PubMed ID: 9415001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise-induced modifications in cardiorespiratory parameters of hypertensive patients treated with calcium antagonists.
    Fariello R; Boni E; Corda L; Muiesan ML; Agabiti-Rosei E
    J Hypertens Suppl; 1991 Dec; 9(3):S67-72. PubMed ID: 1686784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety aspects of treatment with lacidipine--a slow-onset, long-acting calcium antagonist.
    Lindholm LH; Tcherdakoff P; Zanchetti A
    Blood Press; 1996 Jul; 5(4):241-9. PubMed ID: 8809376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of maintenance digoxin therapy on aerobic performance and exercise left ventricular function in mild to moderate heart failure due to coronary artery disease: a randomized, placebo-controlled, crossover trial.
    Fleg JL; Rothfeld B; Gottlieb SH
    J Am Coll Cardiol; 1991 Mar; 17(3):743-51. PubMed ID: 1993796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Kumar A; Aronow WS; Vadnerkar A; Sivan K; Mittal S
    Am J Ther; 2009; 16(1):5-7. PubMed ID: 19142162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term use of K-strophanthin in advanced congestive heart failure due to dilated cardiomyopathy: a double-blind crossover evaluation versus digoxin.
    Agostoni PG; Doria E; Berti M; Guazzi MD
    Clin Cardiol; 1994 Oct; 17(10):536-41. PubMed ID: 8001300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group.
    Sigurdsson A; Amtorp O; Gundersen T; Nilsson B; Remes J; Swedberg K
    Br Heart J; 1994 Nov; 72(5):422-7. PubMed ID: 7818958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of adding torasemide to standard therapy on peak oxygen consumption, natriuretic peptides, and quality of life in patients with compensated left ventricular systolic dysfunction.
    Gupta S; Waywell C; Gandhi N; Clayton N; Keevil B; Clark AL; Ng LL; Brooks N; Neyses L
    Eur J Heart Fail; 2010 Jul; 12(7):746-52. PubMed ID: 20525705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind comparison of the efficacy and safety of lacidipine with atenolol in the treatment of essential hypertension. The United Kingdom Lacidipine Study Group.
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S27-30. PubMed ID: 1726002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.
    Packer M; Gheorghiade M; Young JB; Costantini PJ; Adams KF; Cody RJ; Smith LK; Van Voorhees L; Gourley LA; Jolly MK
    N Engl J Med; 1993 Jul; 329(1):1-7. PubMed ID: 8505940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute hemodynamic and long-term clinical effects of isradipine in patients with coronary artery disease and chronic heart failure. A double-blind, placebo-controlled study.
    van den Toren EW; van Veldhuisen DJ; van Bruggen A; van den Broek SA; van Gilst WH; Lie KI
    Int J Cardiol; 1996 Jan; 53(1):37-43. PubMed ID: 8776276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind comparison of the efficacy and safety of lacidipine and hydrochlorothiazide in essential hypertension. The Southern Italy Lacidipine Study Group.
    Chiariello M
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S35-7. PubMed ID: 1726004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of oral lacidipine on cardiopulmonary function at rest and during exercise in normal subjects.
    Gulotta C; Torchio R; Greco-Lucchina P; Calabrese G
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S55-8. PubMed ID: 1726009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.